High concordance of HER2 amplification between baseline ctDNA and tumour tissue has been demonstrated, and the co-presence of baseline PIK3CA/R1/C3 or ERBB2/4 mutations in ctDNA were associated with poor PFS [33]. This evidence concerns the gene ERBB2 and neoplasm.